Resulting from significant advancements within the pharmaceutical industry, new therapeutic ways are available. However, The shortage of knowledge of the molecular mechanisms governing the destiny of antibodies brings about a problem as a way to discover a curative procedure. The simplest therapeutic strategy needs early prognosis and an optimal nonpharmacological https://www.directivepublications.org/journal-of-arthritis-and-rheumatology/